Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 4:10 pm Purchase | 2024-12-31 | 13G | Foxx Development Holdings Inc. FOXX | Highbridge Capital Management, LLC | 640,057 8.100% | 640,057 (New Position) | Filing History |
| 2025-02-10 5:06 pm Purchase | 2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | Highbridge Capital Management, LLC | 3,633,333 9.200% | 3,633,333 (New Position) | Filing History |
| 2025-02-10 5:04 pm Purchase | 2024-12-31 | 13G | BioAtla, Inc. BCAB | Highbridge Capital Management, LLC | 7,349,205 9.900% | 7,349,205 (New Position) | Filing History |
| 2025-02-07 4:17 pm Unchanged | 2024-12-31 | 13G | VELO3D INC VLDX | Highbridge Capital Management, LLC | 1,187,056 0.600% | 0 (Unchanged) | Filing History |
| 2025-02-07 4:16 pm Unchanged | 2024-12-31 | 13G | EQV Ventures Acquisition Corp. EQV | Highbridge Capital Management, LLC | 10,000 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-07 4:15 pm Purchase | 2024-12-31 | 13G | OnKure Therapeutics, Inc. OKUR | Highbridge Capital Management, LLC | 399,743 3.200% | 399,743 (New Position) | Filing History |
| 2025-02-07 4:15 pm Sale | 2024-12-31 | 13G | Nutex Health, Inc. NUTX | Highbridge Capital Management, LLC | 0 0.000% | -294,592 (Position Closed) | Filing History |
| 2025-01-31 4:15 pm Purchase | 2024-12-31 | 13G | Horizon Space Acquisition II Corp. Units HSPTU | Highbridge Capital Management, LLC | 530,000 5.800% | 530,000 (New Position) | Filing History |
| 2025-01-31 4:15 pm Purchase | 2024-12-31 | 13G | ASPAC III Acquisition Corp. ASPC | Highbridge Capital Management, LLC | 335,000 5.100% | 335,000 (New Position) | Filing History |
| 2025-01-23 4:05 pm Sale | 2025-01-21 | 13D | VERTEX ENERGY INC VTNRQ | Highbridge Capital Management, LLC | 0 0.000% | -1,114,707 (Position Closed) | Filing History |
| 2024-11-14 11:02 am Purchase | 2024-09-30 | 13G | Nutex Health, Inc. NUTX | Highbridge Capital Management, LLC | 294,592 11.000% | 294,592 (New Position) | Filing History |
| 2024-11-14 11:00 am Purchase | 2024-09-30 | 13G | Precision BioSciences, Inc. DTIL | Highbridge Capital Management, LLC | 406,250 5.300% | 406,250 (New Position) | Filing History |
| 2024-11-14 10:31 am Purchase | 2024-09-30 | 13G | VELO3D INC VLDX | Highbridge Capital Management, LLC | 1,187,056 9.900% | 1,187,056 (New Position) | Filing History |
| 2024-11-14 10:30 am Purchase | 2024-09-30 | 13G | Melar Acquisition Corp. I MACI | Highbridge Capital Management, LLC | 1,485,000 9.300% | 1,485,000 (New Position) | Filing History |
| 2024-11-14 10:11 am Purchase | 2024-09-30 | 13G | Reneo Pharmaceuticals, Inc. RPHM | Highbridge Capital Management, LLC | 3,062,690 9.200% | 3,062,690 (New Position) | Filing History |
| 2024-11-14 10:06 am Purchase | 2024-09-30 | 13G | Bakkt Holdings, Inc. BKKT | Highbridge Capital Management, LLC | 692,042 9.900% | 692,042 (New Position) | Filing History |
| 2024-11-14 10:01 am Purchase | 2024-09-30 | 13G | BIORA THERAPEUTICS INC PAR BIORQ | Highbridge Capital Management, LLC | 19,958,480 9.990% | 19,958,480 (New Position) | Filing History |
| 2024-11-08 09:01 am Purchase | 2024-09-30 | 13G | CompoSecure, Inc. CMPO | Highbridge Capital Management, LLC | 3,579,654 4.160% | 275,307 (+8.33%) | Filing History |
| 2024-11-08 09:00 am Unchanged | 2024-09-30 | 13G | Capricor Therapeutics, Inc. CAPR | Highbridge Capital Management, LLC | 2,789,699 6.500% | 0 (Unchanged) | Filing History |
| 2024-11-08 08:33 am Purchase | 2024-09-30 | 13G | SELLAS Life Sciences Group, Inc. SLS | Highbridge Capital Management, LLC | 13,264,712 9.900% | 11,184,658 (+537.71%) | Filing History |